Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.100
+0.055 (1.81%)
Jun 27, 2025, 4:00 PM - Market closed
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $56.70 million as of June 27, 2025. Its market cap has decreased by -3.13% in one year.
Market Cap
56.70M
Enterprise Value
43.61M
1-Year Change
-3.13%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $56.70M, a decrease of -72.84%. That is a compound annual growth rate of -30.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 55.69M | -30.00% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.37B |
| Johnson & Johnson | 366.73B |
| AbbVie | 324.08B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 280.05B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.40B |
| AstraZeneca | 215.99B |